Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review

Abstract

Background: Radiosensitivity is a significantly enhanced reaction of cells, tissues, organs or organisms to ionizing radiation (IR). During radiotherapy, surrounding normal tissue radiosensitivity often limits the radiation dose that can be applied to the tumour, resulting in suboptimal tumour control or adverse effects on the life quality of survivors. Predicting radiosensitivity is a component of personalized medicine, which will help medical professionals allocate radiation therapy decisions for effective tumour treatment. So far, there are no reviews of the current literature that explore the relationship between proteomic changes after IR exposure and normal tissue radiosensitivity systematically. Objectives: The main objective of this protocol is to specify the search and evaluation strategy for a forthcoming systematic review (SR) dealing with the effects of in vivo and in vitro IR exposure on the proteome of human normal tissue with focus on radiosensitivity. Methods: The SR framework has been developed following the guidelines established in the National Toxicology Program/Office of Health Assessment and Translation (NTP/OHAT) Handbook for Conducting a Literature-Based Health Assessment, which provides a standardised methodology to implement the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to environmental health assessments. The protocol will be registered in PROSPERO, an open source protocol registration system, to guarantee transparency. Eligibility criteria: Only experimental studies, in vivo and in vitro, investigating effects of ionizing radiation on the proteome of human normal tissue correlated with radio sensitivity will be included. Eligible studies will include English peer reviewed articles with publication dates from 2011–2020 which are sources of primary data. Information sources: The search strings will be applied to the scientific literature databases PubMed and Web of Science. The reference lists of included studies will also be manually searched. Data extraction and results: Data will be extracted according to a pre-defined modality and compiled in a narrative report following guidelines presented as a “Synthesis without Meta-analyses” method. Risk of bias: The risk of bias will be assessed based on the NTP/OHAT risk of bias rating tool for human and animal studies (OHAT 2019). Level of evidence rating: A comprehensive assessment of the quality of evidence for both in vivo and in vitro studies will be followed, by assigning a confidence rating to the literature. This is followed by translation into a rating on the level of evidence (high, moderate, low, or inadequate) regarding the research question. Registration: PROSPERO Submission ID 220064.

Omics in Radiation Biology: Surprised but Not Disappointed

“…To overcome such possible sources of errors, we support the development of a unified ontology for the findability of studies. We also encourage authors who wish to write conventional or systematic reviews in omics-biology to formulate inclusion and exclusion criteria for removal of such studies, which would be transparently documented in the writing-process [6]. There is a difference in the timeline when the different omics platforms were used to investigate changes in living systems after exposure to IR.…”

Design and development of a multi‐epitope vaccine for the prevention of latent tuberculosis infection

“…Therefore, we assessed the physicochemical properties of the candidate MEV using the Expasy Protparam server (https://web.expasy.org/protparam/). We analyzed parameters such as molecular weight, amino acid composition, half-life in vitro and in vivo, theoretical isoelectric point (pI), instability index, aliphatic index, and grand average of hydropathy (GRAVY), which could impact the potential efficacy of the MEV [48]. We also evaluated the solubility of the candidate MEV using the protein-sol server (https:// protein-sol.manchester.ac.uk/), as the solubility of vaccine is essential in forming the correct spatial structure and inducing an effective immune response.…”

Predicting Normal Tissue Radiotoxicity in Radiotherapy Patients Based on the Individual Radiosensitivity Using Three-Color Fluorescence In Situ Hybridization: A Literature Review

“…Later in 1997, the same investigators assessed 48 blood samples from cancer patients treated with radiotherapy, and 28 patients out of 48 were breast cancer patients [15]. Twelve cancer patients were categorized as the "high or extreme responders".…”